C4 Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:CCCC Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
16 Jan 26	SellUS$22,200	Leonard M. Reyno	Individual		10,000	US$2.22

Insider Trading Volume

Insider Buying: CCCC insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CCCC?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,322,924	1.36%
Public Companies	4,874,550	5%
Hedge Funds	9,439,328	9.67%
General Public	11,131,117	11.4%
VC/PE Firms	15,171,910	15.5%
Institutions	55,638,346	57%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 37.5%.

Top Shareholders

Top 25 shareholders own 80.56% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.67%	Point72 Asset Management, L.P.	9,439,328	US$28.7m	5,780%	0.05%
9.2%	Morgan Stanley	8,974,191	US$27.3m	80.8%	no data
8.2%	RA Capital Management, L.P.	8,000,000	US$24.3m	0%	0.27%
7.35%	Bain Capital Life Sciences Investors, LLC	7,171,910	US$21.8m	545%	2.3%
7.27%	Lynx1 Capital Management LP	7,098,133	US$21.6m	0%	3.55%
5%	Betta Pharmaceuticals Co., Ltd.	4,874,550	US$14.8m	0%	no data
4.49%	The Vanguard Group, Inc.	4,379,815	US$13.3m	37.2%	no data
4.45%	Wasatch Advisors LP	4,344,918	US$13.2m	-10.5%	0.05%
3.9%	Soleus Capital Management, L.P.	3,803,942	US$11.6m	-46.1%	0.48%
2.45%	Bank of America Corporation	2,387,586	US$7.3m	16.3%	no data
2.1%	Susquehanna International Group, LLP	2,047,836	US$6.2m	160%	0.01%
2.04%	Silverarc Capital Management, LLC	1,994,224	US$6.1m	5.1%	0.86%
2.02%	BlackRock, Inc.	1,969,814	US$6.0m	23.5%	no data
1.64%	Renaissance Technologies LLC	1,602,580	US$4.9m	71%	0.01%
1.55%	Two Sigma Investments, LP	1,509,603	US$4.6m	80.9%	0.01%
1.44%	OrbiMed Advisors LLC	1,404,902	US$4.3m	-73.2%	0.06%
1.22%	Millennium Management LLC	1,188,969	US$3.6m	-38.5%	no data
1.1%	The Goldman Sachs Group, Inc.	1,075,244	US$3.3m	150%	no data
1.09%	Two Sigma Advisers, LP	1,068,200	US$3.2m	40%	0.01%
1.01%	Geode Capital Management, LLC	988,878	US$3.0m	36.3%	no data
0.9%	Jane Street Group, LLC	874,794	US$2.7m	330%	no data
0.83%	Wells Fargo & Company	809,260	US$2.5m	4,240%	no data
0.67%	Acadian Asset Management LLC	657,173	US$2.0m	413%	no data
0.5%	Bruce Downey	489,542	US$1.5m	0%	no data
0.46%	Charles Schwab Investment Management, Inc.	449,432	US$1.4m	28.2%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/03/09 11:58
End of Day Share Price	2026/03/09 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

C4 Therapeutics, Inc. is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Etzer Darout	Barclays
Chi Meng Fong	BofA Global Research
Leah Rush Cann	Brookline Capital Markets